Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
186.73B
Market cap186.73B
Price-Earnings ratio
10.47
Price-Earnings ratio10.47
Dividend yield
2.96%
Dividend yield2.96%
Average volume
13.46M
Average volume13.46M
High today
$41.80
High today$41.80
Low today
$40.59
Low today$40.59
Open price
$40.94
Open price$40.94
Volume
11.71M
Volume11.71M
52 Week high
$64.16
52 Week high$64.16
52 Week low
$35.12
52 Week low$35.12

NVO News

The Motley Fool 3h
Prediction: $10,000 Equally Split Between Eli Lilly and Novo Nordisk Will Be Worth This Much by the End of 2027

Eli Lilly (LLY +1.26%) and Novo Nordisk (NVO +2.41%) are leading the fast-growing market for weight loss drugs, but they have had very different fortunes over t...

Prediction: $10,000 Equally Split Between Eli Lilly and Novo Nordisk Will Be Worth This Much by the End of 2027
TipRanks 12h
Novo Nordisk announces results from two post hoc analyses of phase 3 Redefine 1

Novo Nordisk (NVO) announced results from two post hoc analyses of the phase 3 Redefine 1 trial of investigational CagriSema 2.4 mg / 2.4 mg, a fixed-dose combi...

TipRanks 12h
Novo Nordisk presents findings on reduction in food noise when using Wegovy

Novo Nordisk (NVO) presented real-world findings from the Signal and Octane studies at ObesityWeek 2026, looking at how food noise scores changed for adults wit...

Analyst ratings

50%

of 8 ratings
Buy
25%
Hold
50%
Sell
25%

More NVO News

TipRanks 22h
Novo Nordisk Earnings Call Signals Recovery Amid Headwinds

Novo Nordisk ((NVO)) has held its Q3 earnings call. Read on for the main highlights of the call. Novo Nordisk’s earnings call carried a broadly positive tone,...

The Motley Fool 1d
Novo Nordisk vs. Pfizer: Does a Weight Loss or Cancer Focused Pharma Stock Make a Better Buy for 2027?

As the global health landscape shifts toward obesity treatments, investors are weighing the rapid growth of Novo Nordisk A/S (NVO +2.41%) against the deep-roote...

Novo Nordisk vs. Pfizer: Does a Weight Loss or Cancer Focused Pharma Stock Make a Better Buy for 2027?
Simply Wall St 2d
Novo Nordisk Could Be 46% Undervalued After Wegovy Pill Prescription Focus

Novo Nordisk (NYSE:NVO) drew fresh attention after analysts highlighted more than eight million cumulative prescriptions for its oral Wegovy pill and the approa...

Novo Nordisk Could Be 46% Undervalued After Wegovy Pill Prescription Focus
Benzinga 2d
Novo Nordisk Scores EU Win For Hemophilia Drug, Advances Sickle Cell Treatment Toward Approval

Novo Nordisk (NYSE:NVO) announced on Friday that European regulators approved its hemophilia A therapy, Frehemgo, while the company filed U.S. and European mark...

Novo Nordisk Scores EU Win For Hemophilia Drug, Advances Sickle Cell Treatment Toward Approval
TipRanks 2d
Cboe data shows mixed options sentiment in Novo Nordisk with shares up 0.65%

Cboe data shows mixed options sentiment in Novo Nordisk (NVO), with shares up 26c, or 0.65%, near $40.91. Options volume relatively light with 6070 contracts tr...

The Wall Street Journal 3d
Health Care Roundup: Market Talk

george frey / Reuters The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET....

Health Care Roundup: Market Talk
The Motley Fool 4d
JPMorgan Predicted Strong Wegovy Pill Sales (and Was Right). Is Novo Nordisk Stock a Buy Now?

Novo Nordisk (NVO +0.96%) received a vote of confidence from JPMorgan Chase's (JPM +0.39%) analyst ahead of the drug maker's earnings report. The analyst was ex...

JPMorgan Predicted Strong Wegovy Pill Sales (and Was Right). Is Novo Nordisk Stock a Buy Now?

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.